Cell-Based Models of ‘Cytokine Release Syndrome’ Endorse CD40L and Granulocyte–Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell-Based Models of ‘Cytokine Release Syndrome’ Endorse CD40L and Granulocyte–Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy
Authors
Keywords
-
Journal
Cells
Volume 12, Issue 21, Pages 2581
Publisher
MDPI AG
Online
2023-11-06
DOI
10.3390/cells12212581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
- (2023) Vigneshwaran Venkatesan et al. Molecular Therapy-Nucleic Acids
- Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis
- (2023) Viviane Dettmer-Monaco et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
- (2022) Xiaomin Zhang et al. Frontiers in Immunology
- Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
- (2022) Marta García et al. Molecular Therapy-Methods & Clinical Development
- Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
- (2021) Giandomenico Turchiano et al. Cell Stem Cell
- Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data
- (2021) Kevin Bloh et al. CRISPR Journal
- Building on synthetic immunology and T cell engineering: a brief journey through the history of CARs.
- (2021) Hinrich Abken HUMAN GENE THERAPY
- Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques
- (2021) Aisha A. AlJanahi et al. MOLECULAR THERAPY
- CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data
- (2021) Ido Amit et al. Nature Communications
- Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
- (2021) Xinyi Xiao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
- (2021) Frederick L. Locke et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
- (2020) Jie Zhang et al. ADVANCES IN THERAPY
- Automated generation of gene-edited CAR T cells at clinical scale
- (2020) Jamal Alzubi et al. Molecular Therapy-Methods & Clinical Development
- Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-Cells prevents monocyte-dependent release of key cytokine release syndrome mediators
- (2019) Mohit Sachdeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
- (2019) Nicholas F. Kuhn et al. CANCER CELL
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
- (2018) Rosalie M. Sterner et al. BLOOD
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
- (2016) Burkhard Becher et al. IMMUNITY
- Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
- (2016) Shengdar Q. Tsai et al. NATURE REVIEWS GENETICS
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
- (2015) Laurent Poirot et al. CANCER RESEARCH
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search